Your browser doesn't support javascript.
loading
Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial.
Trédan, O; Wang, Q; Pissaloux, D; Cassier, P; de la Fouchardière, A; Fayette, J; Desseigne, F; Ray-Coquard, I; de la Fouchardière, C; Frappaz, D; Heudel, P-E; Bonneville-Levard, A; Fléchon, A; Sarabi, M; Guibert, P; Bachelot, T; Pérol, M; You, B; Bonnin, N; Collard, O; Leyronnas, C; Attignon, V; Baudet, C; Sohier, E; Villemin, J-P; Viari, A; Boyault, S; Lantuejoul, S; Paindavoine, S; Treillleux, I; Rodriguez, C; Agrapart, V; Corset, V; Garin, G; Chabaud, S; Pérol, D; Blay, J-Y.
Affiliation
  • Trédan O; Departments of Medical Oncology, University Claude Bernard.
  • Wang Q; Translational Research and Innovation.
  • Pissaloux D; Translational Research and Innovation.
  • Cassier P; Medical Oncology.
  • de la Fouchardière A; BioPathology, Léon Bérard Cancer center, Lyon.
  • Fayette J; Medical Oncology.
  • Desseigne F; Medical Oncology.
  • Ray-Coquard I; Medical Oncology.
  • de la Fouchardière C; Medical Oncology.
  • Frappaz D; Medical Oncology.
  • Heudel PE; Medical Oncology.
  • Bonneville-Levard A; Medical Oncology.
  • Fléchon A; Medical Oncology.
  • Sarabi M; Medical Oncology.
  • Guibert P; Medical Oncology.
  • Bachelot T; Medical Oncology.
  • Pérol M; Medical Oncology.
  • You B; Department of Medical Oncology, Lyon Sud Hospital Center, CITOHL, Institute of Cancerology, Hospices Civils de Lyon (IC-HCL), Lyon; Faculty of Medicine-Lyon Sud, EMR UCBL/HCL 3738, University of Lyon 1, Oullins.
  • Bonnin N; Department of Medical Oncology, Lyon Sud Hospital Center, CITOHL, Institute of Cancerology, Hospices Civils de Lyon (IC-HCL), Lyon.
  • Collard O; Department of Medical Oncology, Lucien Neuwirth Cancer Institute, Saint-Priest-en-Jarez.
  • Leyronnas C; Department of Medical Oncology, Mutualist Hospital Group, Grenoble.
  • Attignon V; Translational Research and Innovation.
  • Baudet C; Synergie Lyon Cancer, Bio-Informatics Platform.
  • Sohier E; Synergie Lyon Cancer, Bio-Informatics Platform.
  • Villemin JP; Synergie Lyon Cancer, Bio-Informatics Platform.
  • Viari A; Synergie Lyon Cancer, Bio-Informatics Platform.
  • Boyault S; Translational Research and Innovation.
  • Lantuejoul S; BioPathology, Léon Bérard Cancer center, Lyon.
  • Paindavoine S; BioPathology, Léon Bérard Cancer center, Lyon.
  • Treillleux I; BioPathology, Léon Bérard Cancer center, Lyon.
  • Rodriguez C; BioPathology, Léon Bérard Cancer center, Lyon.
  • Agrapart V; Department of Clinical Research and Innovation, Léon Bérard Cancer Center, Lyon, France.
  • Corset V; Department of Clinical Research and Innovation, Léon Bérard Cancer Center, Lyon, France.
  • Garin G; Department of Clinical Research and Innovation, Léon Bérard Cancer Center, Lyon, France.
  • Chabaud S; Department of Clinical Research and Innovation, Léon Bérard Cancer Center, Lyon, France.
  • Pérol D; Department of Clinical Research and Innovation, Léon Bérard Cancer Center, Lyon, France.
  • Blay JY; Departments of Medical Oncology, University Claude Bernard. Electronic address: jean-yves.blay@lyon.unicancer.fr.
Ann Oncol ; 30(5): 757-765, 2019 05 01.
Article in En | MEDLINE | ID: mdl-30865223
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mutation / Neoplasm Recurrence, Local / Neoplasms Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adult / Child / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2019 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mutation / Neoplasm Recurrence, Local / Neoplasms Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adult / Child / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2019 Type: Article